,,iv #aai? ,,congress #a/ ,session ,h4 ,,res4 #bgg ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #ca1 #bjbe,mr4 ,mc,cormick submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,support+ ! designation ( ,may #bjbe z ,national ,myositis ,aw>5ess ,mon?4 ,:]eas resid5ts ( ! ,unit$ ,/ates ( ,am]ica are among ^? affect$ by myositis & o!r r>e diseases1 ) ne>ly #a 9 #aj ,am]icans hav+ r>e diseases2 ,:]eas idiopa?ic inflammatory myopa?ies 7collectively ref]r$ to z myositis7 are r>e1 *ronic1 autoimmune muscle-wa/+ diseases t (t5 feature debilitat+ muscle inflammation & o!r symptoms1 su* z pa91 fatigue1 & tr\ble swall[+1 & c result 9 myositis-associat$ int]/itial lung disease2 ,:]eas m rese>* is ne$$ to id5tify ! causes ( & modes ( treatm5ts = ! myositis gr\p ( diseases1 :i* includes anti-,,mda#e autoantibody-positive myositis1 antisyn!tase syndrome1 d]matomyositis1 juv5ile d]matomyositis1 immune-m$iat$ necrotiz+ myopa?y1 inclusion body myositis1 & polymyositis2 ,:]eas myositis is difficult to diagnose :i* leads myositis pati5ts to frequ5tly exp]i5ce delay$ treatm5t & difficulty f9d+ a heal? c>e provid] ) exp]tise 9 _! condition2 ,:]eas all :o suff] ) myositis exp]i5ce r$uc$ quality ( life1 p>ticul>ly s9ce no cure has be5 f\nd & life expectancy is %ort5$1 especially = ^? ) inclusion body myositis1 & wom5 & p ( color ) all =ms ( myositis exp]i5ce p>ticul>ly pron\nc$ heal? disp>ities2 & ,:]eas public aw>5ess & education campaigns on myositis detection & treatm5t are held dur+ ! mon? ( ,may3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! designation ( ,national ,myositis ,aw>5ess ,mon?2 7#b7 recognizes ! importance ( rais+ aw>5ess ab\t myositis & its impact on ,unit$ ,/ates vet]ans & citiz5s2 & 7#c7 enc\rages all p 9 ! ,unit$ ,/ates to become m in=m$ ab\t myositis & to support ! individuals & families :o are affect$ by ^! conditions4